The starting dose is 2 mg per week
We are your ally in effective, sustainable weight management
However, arthralgia is a recognised adverse reaction with approved incretin-based therapies, and any joint symptoms during a trial should be reported to the trial team
At the same time as these investigations were happening, similar work was being undertaken by Ole Dragsbk Madsen, a Danish scientist working thirty minutes away at Novo Nordisk's Hagedorn Research Institute
Peptides 15: 675-681, 1994
Questions to Ask When consulting about Retatrutide, consider asking about starting doses, expected timeline for results, potential interactions, and monitoring requirements